Adult Congenital Heart Disease Clinical Trials

9 recruiting

Adult Congenital Heart Disease Trials at a Glance

9 actively recruiting trials for adult congenital heart disease are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 1 trial, with the heaviest enrollment activity in Bologna, Leiden, and Columbus. Lead sponsors running adult congenital heart disease studies include IRCCS Azienda Ospedaliero-Universitaria di Bologna, Leiden University Medical Center, and Anita Saraf.

Browse adult congenital heart disease trials by phase

Treatments under study

About Adult Congenital Heart Disease Clinical Trials

Looking for clinical trials for Adult Congenital Heart Disease? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Adult Congenital Heart Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Adult Congenital Heart Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting

Psychological Trauma, Post-Traumatic Stress Disorder, and Resilience in Adults With Congenital Heart Disease

Congenital Heart DiseasePTSDAdult Congenital Heart Disease
Dartmouth-Hitchcock Medical Center1,000 enrolled3 locationsNCT06952933
Recruiting

Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders

Pulmonary HypertensionConnective Tissue DiseaseAdult Congenital Heart Disease+1 more
Children's Hospital Medical Center, Cincinnati5,000 enrolled1 locationNCT07477197
Recruiting

Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry

Congenital Heart DiseaseAdult Congenital Heart DiseaseSystemic Right Ventricle+5 more
Leiden University Medical Center400 enrolled11 locationsNCT06932081
Recruiting
Phase 4

Efficacy Of Sodium Glucose Transporter Inhibitor (SGLT2I) In Adult Patients With Congenital Heart Disease

Heart FailureAdult Congenital Heart Disease
Anita Saraf40 enrolled3 locationsNCT06260059
Recruiting

Real-World Data on the Effects of Cardiac Resynchronization Therapy in Adult Patients With Congenital Heart Disease

Adult Congenital Heart Disease
Leiden University Medical Center100 enrolled1 locationNCT06969924
Recruiting

Observational Cohort Study of Adult Patients With Congenital Heart Disease

Adult Congenital Heart Disease
IRCCS Azienda Ospedaliero-Universitaria di Bologna2,000 enrolled1 locationNCT06769529
Recruiting
Not Applicable

Search for Noninvasive Markers of "Graft Injury" in Pediatric and Adult Patients With Congenital Heart Disease Undergoing Cardiac Transplantation

Adult Congenital Heart DiseaseCongenital Heart Disease (CHD)Heart Transplant Patients+1 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna20 enrolled1 locationNCT06784440
Recruiting

Should we Avoid Performing Invasive Coronary Angiography Before Cardiac Surgery in ACHD Patients?

Adult Congenital Heart Disease
IRCCS Azienda Ospedaliero-Universitaria di Bologna80 enrolled1 locationNCT06775639
Recruiting

Prognosis in Adult Patients With Congenital Heart Disease

Adult Congenital Heart Disease
Fondazione Policlinico Universitario Agostino Gemelli IRCCS450 enrolled1 locationNCT06723704